TEST:

CyPath® Lung

Mail out lung cancer tests then. CyPath Lung will end the stigma and excuses. You spend a few minutes for a few days at home coughing to clear your lungs, and that will tell you with high accuracy whether you have #lungcancer. (@DrAaronThomason)

Really, dead last? Mayor, you may want to have some people look at CyPath Lung, which is a brand new non-invasive early lung cancer detection test. @bioAffinity licenses it to pathology labs, and Hawaii will need a local lab to process samples. This test has amazing accuracy. (@DrAaronThomason)

It is a rapidly changing landscape, and I was hoping to hear about CyPath Lung which will change the sequence that the doctor laid out about the determination of whether someone has lung cancer. When ordered with every LDCT, CyPath Lung can catch the earliest of cancer. It also… https://t.co/MLE69MHNQ4 (@DrAaronThomason)

Asian women in the U.S. are apparently experiencing higher cases of lung cancer as well having never smoked. That's why we need more widely available testing. CyPath Lung could easily be an annual test we give everyone. They haven't done studies though of never smokers. The CEO… https://t.co/jWv6LbKMrc (@DrAaronThomason)

This confirms everyone should be getting #lungcancer screening. If only a non-invasive radiation-free early detection test existed. IF ONLY. Wait a minute, what is this #CyPathLung early detection, non-invasive, at-home, radiation-free test that analyzes sputum with higher… https://t.co/mTa7iku0xN (@DrAaronThomason)

Congratulations. Can I suggest you schedule a call with @bioAffinity on their new #CyPathLung product that is launching this year? I met everyone yesterday including the scientists. You should hear why they have gotten lung sputum this accurate at detecting #lungcancer. (@DrAaronThomason)

#CyPathLung. That's what your healthcare system needs. Lung cancer screening would soar if you adopt this non-invasive at-home test. Using a new TCPP detection technique, this test has the same accuracy as a biopsy. 92% sensitivity and 87% specificity. That's a breakthrough. (@DrAaronThomason)

Question. So Australia is looking to increase lung cancer screening and hopefully reduce deaths. Have you learned of #CyPathLung by @bioAffinity? You need to. It has incredible accuracy, and it's non-invasive. You can mail it out. Imagine the jump in the screening rate. (@DrAaronThomason)

You can use this to detect lung cancer. #CyPathLung by @bioAffinity has 92% sensitivity and 87% specificity for the early detection of lung cancer. It's available in Texas now and nationwide soon. People are excited about this test. You can find their research here.… https://t.co/fJ0G2mjELN (@DrAaronThomason)

Hook you some CyPath Lung next year. Available in Texas, developed in Texas, non-invasive test for early detection of lung cancer. By @bioAffinity. (@DrAaronThomason)

Here's something you can do about lung cancer. Tell people there's at-home non-invasive test for lung cancer. It's in the U.S. and one of the inventors is from the Netherlands. It's as accurate as a biopsy. Learn more. You need it in the EU. #CyPathLung (@DrAaronThomason)

I'm curious if #CyPathLung has popped up in your conversations? It launches commercially in the U.S. this year, and it is going to change #lungcancer #screening rates dramatically. It offers high accuracy as a non-invasive option. That's going to get people off the couch. I… https://t.co/ilinPY7E99 (@DrAaronThomason)

Did anybody mention the new non-invasive test that will have a profound effect on the national screening rate for lung cancer? #CyPathLung can be ordered after a positive LDCT result, and it offers 92% sensitivity and 87% specificity for the early detection of lung cancer. Only… https://t.co/fzeITpBXG5 (@DrAaronThomason)

One way to increase access to cancer screening is at-home lung cancer testing. Not everyone has access to low-dose CT, and honestly a 96% false positive rate deters people from getting screened. However, #CyPathLung is at-home, non-invasive test with accuracy on par with biopsy. (@DrAaronThomason)